XML 30 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Information
9 Months Ended
Sep. 30, 2016
Segment Reporting [Abstract]  
Reportable Segments
Segment Information:

Effective January 1, 2016, our former Performance Chemicals reportable segment was split into two reportable segments: (1) Lithium and Advanced Materials and (2) Bromine Specialties. In addition, on June 17, 2016, the Company signed a definitive agreement to sell its Chemetall Surface Treatment business to BASF SE. This business, a separate reportable segment, is classified as discontinued operations and its results are excluded from segment results for all periods presented. As a result, our three reportable segments include Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. The new business structure aligns with the markets and customers we serve through each of the segments. The new structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions.
Summarized financial information concerning our reportable segments is shown in the following tables. Results for 2015 have been recast to reflect the change in segments noted above.
The “All Other” category comprises three operating segments that do not fit into any of our core businesses subsequent to the acquisition of Rockwood: minerals-based flame retardants and specialty chemicals, fine chemistry services and metal sulfides. During the first quarter of 2016, we completed the sales of the metal sulfides business and the minerals-based flame retardants and specialty chemicals businesses. For additional information about these businesses, see Note 3, “Divestitures.”
The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the reportable segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs.
The Company’s chief operating decision maker uses earnings before interest, taxes, depreciation and amortization, as adjusted on a consistent basis for certain non-recurring or unusual items such as acquisition and integration related costs, utilization of inventory markup, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, non-operating pension and OPEB items and other significant non-recurring items (“adjusted EBITDA”), in a balanced manner and on a segment basis to assess the ongoing performance of the Company’s business segments and to allocate resources. In addition, management uses adjusted EBITDA for business planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP.
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
 
2016
 
2015
 
2016
 
2015
 
(In thousands)
Net sales:
 
 
 
 
 
 
 
Lithium and Advanced Materials
$
240,424

 
$
208,820

 
$
689,950

 
$
620,597

Bromine Specialties
194,496

 
190,716

 
597,912

 
604,267

Refining Solutions
190,453

 
185,102

 
539,044

 
528,841

All Other
28,272

 
102,224

 
150,987

 
337,997

Corporate
365

 
6,354

 
2,655

 
12,117

Total net sales
$
654,010

 
$
693,216

 
$
1,980,548

 
$
2,103,819

 
 
 
 
 
 
 
 
Adjusted EBITDA:
 
 
 
 
 
 
 
Lithium and Advanced Materials
$
91,719

 
$
77,408

 
$
260,861

 
$
234,988

Bromine Specialties
51,807

 
58,801

 
179,977

 
180,431

Refining Solutions
64,960

 
54,517

 
181,620

 
144,910

All Other
5,470

 
6,262

 
14,810

 
29,540

Corporate
(25,627
)
 
(16,307
)
 
(66,435
)
 
(8,350
)
Total adjusted EBITDA
$
188,329

 
$
180,681

 
$
570,833

 
$
581,519


See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, (in thousands):
 
Lithium and Advanced Materials
 
Bromine Specialties
 
Refining Solutions
 
Reportable Segments Total
 
All Other
 
Corporate
 
Consolidated Total
Three months ended September 30, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to Albemarle Corporation
$
66,166

 
$
41,621

 
$
55,981

 
$
163,768

 
$
3,806

 
$
(39,354
)
 
$
128,220

Depreciation and amortization
25,553

 
10,186

 
8,979

 
44,718

 
1,664

 
1,592

 
47,974

Acquisition and integration related costs(a)

 

 

 

 

 
6,749

 
6,749

Interest and financing expenses

 

 

 

 

 
15,946

 
15,946

Income tax expense

 

 

 

 

 
12,394

 
12,394

Income from discontinued operations (net of tax)

 

 

 

 

 
(23,185
)
 
(23,185
)
Non-operating pension and OPEB items

 

 

 

 

 
(231
)
 
(231
)
Other(b)

 

 

 

 

 
462

 
462

Adjusted EBITDA
$
91,719

 
$
51,807

 
$
64,960

 
$
208,486

 
$
5,470

 
$
(25,627
)
 
$
188,329

Three months ended September 30, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to Albemarle Corporation
$
38,498

 
$
49,395

 
$
45,713

 
$
133,606

 
$
617

 
$
(68,831
)
 
$
65,392

Depreciation and amortization
22,076

 
9,406

 
8,804

 
40,286

 
5,645

 
2,712

 
48,643

Utilization of inventory markup(c)
16,834

 

 

 
16,834

 

 

 
16,834

Restructuring and other, net(d)

 

 

 

 

 
(6,804
)
 
(6,804
)
Acquisition and integration related costs(a)

 

 

 

 

 
36,514

 
36,514

Interest and financing expenses

 

 

 

 

 
19,294

 
19,294

Income tax expense

 

 

 

 

 
13,144

 
13,144

Income from discontinued operations (net of tax)

 

 

 

 

 
(11,030
)
 
(11,030
)
Non-operating pension and OPEB items

 

 

 

 

 
(1,306
)
 
(1,306
)
Adjusted EBITDA
$
77,408

 
$
58,801

 
$
54,517

 
$
190,726

 
$
6,262

 
$
(16,307
)
 
$
180,681

Nine months ended September 30, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to Albemarle Corporation
$
186,373

 
$
150,221

 
$
154,767

 
$
491,361

 
$
133,012

 
$
(582,788
)
 
$
41,585

Depreciation and amortization
74,488

 
29,756

 
26,853

 
131,097

 
5,629

 
4,562

 
141,288

(Gain) loss on sales of businesses, net(e)

 

 

 

 
(123,831
)
 
1,533

 
(122,298
)
Acquisition and integration related costs(a)

 

 

 

 

 
44,337

 
44,337

Interest and financing expenses

 

 

 

 

 
46,860

 
46,860

Income tax expense

 

 

 

 

 
61,535

 
61,535

Loss from discontinued operations (net of tax)

 

 

 

 

 
357,843

 
357,843

Non-operating pension and OPEB items

 

 

 

 

 
(779
)
 
(779
)
Other(b)

 

 

 

 

 
462

 
462

Adjusted EBITDA
$
260,861

 
$
179,977

 
$
181,620

 
$
622,458

 
$
14,810

 
$
(66,435
)
 
$
570,833

Nine months ended September 30, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to Albemarle Corporation
$
88,219

 
$
154,353

 
$
119,513

 
$
362,085

 
$
9,644

 
$
(211,075
)
 
$
160,654

Depreciation and amortization
67,530

 
26,078

 
25,397

 
119,005

 
16,867

 
6,933

 
142,805

Utilization of inventory markup(c)
79,239

 

 

 
79,239

 
3,029

 

 
82,268

Restructuring and other, net(d)

 

 

 

 

 
(6,804
)
 
(6,804
)
Acquisition and integration related costs(a)

 

 

 

 

 
117,171

 
117,171

Interest and financing expenses

 

 

 

 

 
62,193

 
62,193

Income tax expense

 

 

 

 

 
41,780

 
41,780

Income from discontinued operations (net of tax)

 

 

 

 

 
(19,074
)
 
(19,074
)
Non-operating pension and OPEB items

 

 

 

 

 
(3,915
)
 
(3,915
)
Other(f)

 

 

 

 

 
4,441

 
4,441

Adjusted EBITDA
$
234,988

 
$
180,431

 
$
144,910

 
$
560,329

 
$
29,540

 
$
(8,350
)
 
$
581,519


(a)
See Note 2, “Acquisitions,” for additional information.
(b)
Includes the write-off of fixed assets of $1.4 million included in Research and development expenses, partially offset by a net gain of $0.9 million on the sales of properties included in Other income, net.
(c)
In connection with the acquisition of Rockwood, the Company valued Rockwood’s existing inventory at fair value as of the Acquisition Closing Date, which resulted in a markup of the underlying net book value of the inventory totaling approximately $103.4 million. The inventory markup was expensed over the estimated remaining selling period. For the three-month and nine-month periods ended September 30, 2015, $7.7 million and $55.4 million, respectively, was included in Cost of goods sold, and Equity in net income of unconsolidated investments was reduced by $9.1 million and $26.9 million, respectively, related to the utilization of the inventory markup.
(d)
Gain recognized upon the sale of land in Avonmouth, UK, which was utilized by the phosphorus flame retardants business we exited in 2012.
(e)
See Note 3, “Divestitures,” for additional information.
(f)
Financing-related fees expensed in connection with the acquisition of Rockwood.